Former India cricketer Ravi Shastri recently came forward and heaped praise on star India pacer Mohammed Shami. He opined that he was delighted to see Shami get his mojo back after being injured.

Mohammad Amir, the former Pakistani pacer, has openly stated his preference for playing in the Indian Premier League (IPL) over the Pakistan Super League (PSL). Aiming to obtain a UK passport ...

During a practice session, Rohit was spotted sitting with LSG mentor Zaheer Khan when pacer Shardul Thakur walked in. Wasting no time, Rohit teased Shardul for showing up late to practice ...

New Delhi: The Mumbai Indians, led by Hardik Pandya, have significantly improved their performance in the IPL 2025 playoffs race. Following a slow start with only one win in their first five ...

With Takeda’s £46 billion acquisition of Shire, it’s been a busy year for pharma M&A – and according to analysts Datamonitor, the specialist biotechs Nektar, BioMarin and Alnylam are the ...

Rohit Sharma couldn't make it three fifties in a row on Sunday, falling shortly after smashing Mayank Yadav for two back-to-back sixes. Rohit Sharma had returned to run-scoring in style over ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

PT101 is an engineered IL-2 mutein fused to a protein backbone, and is vying to come to market along with other IL-2-based therapies, notably Eli Lilly and Nektar Therapeutics’ phase 2 candidate ...

The Indian Premier League 2025 season is captivating cricket fans worldwide, with all 10 franchises loaded up with star players and rookies in the ongoing tournament. SIGN UP & BET on the ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Nektar Therapeutics before investing. In this article, we go over a few key ...